Pharma Finance and Investment News
New Africa / Shutterstock.com
ILC Therapeutics completes £2.5m financing round and bolsters C-suite
ILC Therapeutics, a specialist developer of hybrid interferons, a new drug class engineered for improved therapeutic profiles across multiple indications, has announced that it has successfully completed a fundraise of £2.5m. Read more
11 Sep 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Lightspring / Shutterstock.com
Mestag Therapeutics awarded £1.5m Innovate UK grant to accelerate the Path to Clinic for MST-0300
Mestag Therapeutics has announced that it has been awarded a “Transforming Cancer Therapeutics” grant from Innovate UK’s Cancer Therapeutics program of £1.5 million to accelerate the development of its MST-0300 antibody. Read more
28 Aug 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Abselion
Abselion announces £1.1m project to develop next-gen cell platform for viral vector production
Biotechnology companies and research organisations in the UK and Canada are entering into a R&D project jointly funded by a 1.1 million GBP grant from Innovate UK and the National Research Council of Canada Industrial Research Assistance Program. Read more
21 Aug 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Oncimmune
Oncimmune Holdings wins $1.5m contract with top 10 pharma company
Oncimmune Holdings, an autoantibody profiling company providing research services to the pharmaceutical and biotechnology industry to enable the delivery of precision medicine, has announced a new contract win with a top 10 global pharma company. Read more
12 Aug 2024
Pharma Manufacturing News + Pharma Finance and Investment News
khunkornStudio / Shutterstock.com
Asceneuron secures $100m funding to advance therapeutics in neurodegenerative diseases
Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root cause of neurodegenerative disease, has announced a 100 million USD oversubscribed Series C financing round. Read more
18 Jul 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Rhenopharma Group
Rhenopharma Group acquires Swiss contract manufacturer Konapharma AG
Within the new group of companies, Konapharma now complements the services of packaging company Allpack and Rhenochem, a family-owned company with decades of extensive experience and expertise in the global pharmaceutical industry. Read more
1 Jul 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Shutterstock
Cycle Pharma Offers $466 Million to Acquire Vanda Pharmaceuticals
Cycle Pharmaceuticals a rapidly growing pharmaceutical company focused on treatments for the underserved rare disease patient community, have confirmed that it made a proposal to the Board of Directors of Vanda Pharmaceuticals, Inc. Read more
10 Jun 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Shutterstock
Nuclera Awarded £1.14M Innovate UK Funding
Nuclera have announced it has been awarded two highly competitive Innovate UK grants totalling £1.14M. Read more
7 Jun 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Shutterstock
Alchemab Receive Grant From The Michael J. Fox Foundation
Alchemab Therapeutics has been awarded a grant of $595,000 by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support its Parkinson’s disease program. Read more
7 Jun 2024
Pharma Manufacturing News + Pharma Finance and Investment News
TierneyMJ / Shutterstock.com
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more
Biocomposites Confirms NanoBone UK Distribution
Containing the NanoBone SBX Putty and NanoBone QD solutions, NanoBone products aim to provide synthetic bone grafts for reliable, early osteogenesis and bone formation. Read more
13 Sep 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Tanveer Nadeem Shutterstock
OncoHost accepted to present poster at ESMO 2024
OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, has announced its selection to present a poster at the European Society of Medical Oncology (ESMO) Congress 2024. Read more
13 Sep 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Cellular Origins
New collaboration set to integrate cryoFIL platform with Constellation robotic system
Cellular Origins has announced a collaboration with 3P innovation to integrate 3P's cryoFIL cryovial filling platform within Cellular Origins’ robotic system, Constellation, expanding the system’s capabilities by enabling automated filling Read more
12 Sep 2024
Pharma Manufacturing News + Pharmaceutical Manufacturing News
Arrowhead Pharmaceuticals’ Plozasiran Receives Breakthrough Therapy Designation from the FDA
The treatment has the potential to reduce triglycerides and other atherogenic lipoproteins. Read more
12 Sep 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
BGS US
BGS Beta-Gamma-Service announces US expansion plans
BGS Beta-Gamma-Service, a specialist for more than 40 years in the use of beta and gamma rays for radiation sterilisation for medical devices, pharmaceutical packaging, and biotechnology products, will open its first facility in the United States. Read more
12 Sep 2024
New Africa / Shutterstock.com
ILC Therapeutics completes £2.5m financing round and bolsters C-suite
ILC Therapeutics, a specialist developer of hybrid interferons, a new drug class engineered for improved therapeutic profiles across multiple indications, has announced that it has successfully completed a fundraise of £2.5m. Read more
11 Sep 2024
Pharma Manufacturing News + Pharma Finance and Investment News
